P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
Main Authors: | Mia Lohmann, Iris Buchberger, Anna Beielstein, Başak Kaçar, Julia Mattlener, Marieke Nill, Zhiyuan Shi, Jan-Michel Heger, Christian Pallasch, Roland Ullrich, Sven Borchmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000890752.16913.40 |
Similar Items
-
P037: High breadth whole exome sequencing of circulating tumor DNA identifies novel recurrent genetic alterations in Hodgkin lymphoma
by: Laman Mammadova, et al.
Published: (2022-10-01) -
S236: HIGH-BREADTH SEQUENCING OF CIRCULATING TUMOR DNA IDENTIFIES NOVEL CLASSIFICATION OF HODGKIN LYMPHOMA
by: Jan-Michel Heger, et al.
Published: (2023-08-01) -
Generation and characterization of three induced pluripotent stem cell lines (NUIGi046-A, NUIGi046-B, NUIGi046-C) from a 51-year-old healthy individual
by: Min Liu, et al.
Published: (2021-12-01) -
EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer
by: Carolin Selenz, et al.
Published: (2022-08-01) -
P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma
by: Zhiyuan Shi, et al.
Published: (2022-10-01)